A carregar...
NT-20 TARGETING CDK4 AND 6 IN THE CLASSICAL SUBTYPE OF GLIOBLASTOMA
BACKGROUND: Glioblastoma is highly refractory to conventional treatment approaches. Since the introduction of concomitant and adjuvant temozolomide and radiotherapy, patients with glioblastoma have shown little improvement in the median survival time of just 15 months. Inhibitors that target the cel...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218427/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou265.18 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|